Alzheimer's Research
To learn more about Alzheimer’s, memory loss and ongoing clinical trials in this area, visit our Alzheimer’s Disease Research page.
Learn MoreThe main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease dementia. This is done by looking at participants: thinking and memory (cognition), everyday activities and sleep, AD symptoms, physical activity, irritability or anxiety.
Have Alzheimer’s disease (AD) with gradual and progressive decline in memory function for greater than or equal to 6 months
Have a reliable study partner who will participate in the study to support the participant
Be males with partners of childbearing potential must agree to abide with provided contraception guidance
Have prior central nervous system or psychiatric disease other than AD
Have history of cardiovascular or liver disorders
Be currently enrolled or intend to enroll in a clinical trial of another investigational product
Have suicidal tendencies
To learn more about Alzheimer’s, memory loss and ongoing clinical trials in this area, visit our Alzheimer’s Disease Research page.
Learn MoreTo learn more about neurological disorders and ongoing clinical trials in the area, visit our Neurological Disorders Research page.
A clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.